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The organization of specific pyrimidine pathways to channel various nucleoside precursors into DNA is 
poorly understood. We show that concanavalin A-stimulated guinea pig lymphocytes incorporate [3H]dThd, 
pH]dCyd, [3H]dUrd, [3H]Cyd and [aH]Urd into DNA-thymines and DNA-cytosines in a highly conserved 
distribution pattern. DNA-thymines were labeled only by dThd and dUrd, while DNA-cytosines were la- 
beled only by dCyd, Cyd and Urd. The kinetics for the incorporation of the [3H]nucleosides were essentially 
identical, indicating equivalent abilities to measure DNA synthesis. Pyrazofurin inhibition of the pyrimidine 
de novo synthetic pathway inhibited cell proliferation and the levels of [3H]nucleoside incorporation by ap- 
prox. 50%, but did not alter restricted istribution of the [3H]nucleosides among DNA-thymines and DNA- 
cytosines. These findings indicate the absence of Cyd and dCMP deaminase salvage pathways and suggest 
either subcellular compartmentalization or differential regulation of ribonucleoside diphosphoreductase 
which permits reduction of CDP but not UDP. 
DNA synthesis; Pyrimidine salvage pathway; Pyrimidine de novo synthesis; Metabolic hanneling; 
Pyrazofurin; Concanavalin A-stimulated T-lymphocyte 
1. INTRODUCTION 
Manipulation of lymphocyte proliferation with 
exogenous nucleosides and nucleoside analogs has 
proven useful in elucidation of nucleoside nzyme 
deficiencies associated with certain forms of in- 
herited immunodeficiency disease [1,2] and the 
development of anti-cancer agents for use in lym- 
phoid malignancies [3]. In order to further utilize 
various nucleosides and their interrelationships 
with lymphocyte cytotoxicity and cellular 
metabolism, an evaluation is needed of nucleoside 
metabolism and function in the context of 
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subcellular compartmentalization a d processing 
by multi-enzyme complexes [4]. Separate 
subcellular compartments of deoxynucleoside 
triphosphate pools for DNA synthesis [5-7] and 
multi-enzyme complexes capable of channeling 
dNTP precursors during synthesis without free ac- 
cess to intracellular pools [8,9] have been shown to 
exist. However, little is known about the compart- 
mentalization of enzymes and metabolites involved 
in de novo and salvage pathway synthesis of deox- 
yribonucleotides. 
Numerous studies have monitored the incor- 
poration of various radioactive metabolites into 
lymphocyte DNA by monitoring acid insoluble 
fractions of cell lysates. Many of these studies have 
relied on the incorporation of the salvage pathway 
precursor, [3H]dThd, as a specific marker for 
DNA synthesis. Somewhat offsetting the conve- 
nience of using [3H]dThd to measure DNA syn- 
thesis is the awareness that the extent or even the 
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absence of [3H]dThd incorporation [5,8,10,11] 
may not accurately reflect the amount of DNA 
synthesis in a particular cell type. The use of other 
radiolabeled pyrimidine precursors from either the 
de novo or salvage pathway as alternative in- 
dicators of DNA synthesis hare the complexities 
of possibly labeling RNA and DNA and being 
distributed among DNA-Thy as well as DNA-Cyt. 
In the following studies we used HPLC analysis 
of isolated DNA hydrolysates to examine the abili- 
ty of various radiolabeled nucleosides to label 
DNA-Thy and DNA-Cyt in concanavalin A- 
induced proliferation of guinea pig T- 
lymphocytes. These labeling patterns provide in- 
formation about the various pyrimidine salvage 
pathways which are involved in supporting DNA 
synthesis, and are intended to generate informa- 
tion about subcellular compartmentalization f 
DNA precursors and interrelationships between 
these pathways and exogenously supplied 
nucleosides. 
2. MATERIALS AND METHODS 
2.1. DNA labeling and isolation 
Lymphocytes were isolated from axillary, 
popliteal and inguinal lymph nodes of male 
Hartley strain guinea pigs (Biolab Corporation, St 
Paul, MN) that had been sensitized 7 days earlier 
with Freund's complete adjuvant (Difco, Detroit, 
MI). Lymphocytes were teased into suspension in 
Eagles' minimum essential medium (Gibco, Grand 
Island, NY) and filtered once through a stainless 
steel screen. Cells were washed twice by centrifuga- 
tion at 600 × g and were seeded at 1 × 10 6 cells/ml 
in medium which contained 10/~g/ml of Con A 
(Sigma, St Louis, MO). Increases in cell number 
were routinely estimated as the increase in total 
cellular protein as measured by the method of 
Lowry et al. [12]. Lymphocyte DNA was labeled 
by adding to the culture medium 1/zCi/ml of 
[methyl-3H]dThd (6.7 Ci/mM), [6-3H]dUrd (21.4 
Ci/mM), [5-3H]dCyd (25.6 Ci/mM), [G-3H]Urd 
(6.0 Ci/mM), [5-3H]Cyd (21.0 Ci/mM), or  [6-14C] - 
orotic acid (51.3 mCi/mM) from New England 
Nuclear (Boston, MA). All radiolabeled com- 
pounds were checked for purity by HPLC analysis 
prior to use. Labeling of cells (25 × 106/data point) 
was initiated at 22 h after Con A stimulation and 
terminated at 52 h for samples used to determine 
radioactivity distributions among DNA bases. 
Shorter periods, i.e., 3 to 12 h, of culture in the 
presence of radioactive precursors were used in 
studies to determine relative rates of uptake into 
DNA. The incorporation for precursors was essen- 
tially linear through 22 h, slowed at 22-30 h, and 
leveled by 40-48 h. All culture periods were ter- 
minated by decanting the culture medium and im- 
mediately adding 25 ml of a solution containing 
0.15 M NaC1, 0.1 M EDTA, 20 mg/ml of SDS, 
and nuclei from 40 g of rat liver. This mixture was 
heated 10 min at 60°C, and DNA was isolated as 
described [13]. DNA concentrations were based on 
a colorimetric assay following the method of Bur- 
ton [14]. In experiments using pyrazofurin, 10/~M 
pyrazofurin was added at the beginning of culture 
along with Con A and was present hroughout the 
experiment. For experiments in which nucleosides 
were added to reverse pyrazofurin inhibition, 
75/~M nucleoside was added with pyrazofurin and 
was present hroughout the culture period. 
2.2. HPLC analysis of DNA radiolabeling 
To determine which DNA bases were labeled by 
a particular radioprecursor, isolated DNA was 
hydrolyzed to purine and pyrimidine bases in 98% 
formic acid and the bases separated by HPLC on 
a Supelcosil LC-18-DB column (Supelco, 
Bellefonte, PA) using isocratic elution with a buf- 
fer containing 5 mM KHzPO4 (pH 4.0) and 0.1% 
tetrahydrofuran [15]. A typical analysis consisted 
of injecting 2000-8000 cpm of DNA hydrolysate, 
collecting 0.5 ml fractions and determining 
radioactivity content by liquid scintillation 
counting. Recovery of injected radioactivity was 
94-98%. 
3. RESULTS 
3.1. Labeling of DNA-Thy and DNA-Cyt by 
[3 Hlnucleosides 
We first determined the distribution of various 
radiolabeled nucleoside precursors among DNA- 
pyrimidines of guinea pig lymphocytes replicating 
in response to Con A stimulation. Shown in fig.1 
are 3H-labeling distributions for the incorporation 
of the salvage pathway precursors, [3H]dThd, 
[3H]dCyd, [3H]dUrd, [3H]Cyd, [3H]Urd, and the 
de novo pathway pyrimidine precursor, [14C]orotic 
acid. While the de novo pathway precursor labeled 
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both DNA-Thy and DNA-Cyt, the salvage 
pathway precursors were greatly restricted with 
respect to their labeling distributions, i.e., 
[3H]dThd and [3H]dUrd labeled only DNA-Thy; 
Fig. 1. Distribution of radioactivity among DNA bases as 
labeled by various radioisotopic DNA precursors during 
Con A-stimulated lymphocyte proliferation. DNA was 
isolated from cultured lymphocytes, hydrolyzed then 
chromatographed as described in section 2. The top 
panel depicts the absorbance profile for HPLC 
separation of nucleic acid bases. C, cytosine; M, 
5-methylcytosine; U, uracil; G, guanine; T, thymine; A, 
adenine; OA, orotic acid; dT, dThd; dU, dUrd; dC, 
dCyd; rC, Cyd; rU, Urd. 
[3H]dCyd, [3H]Cyd and [3H]Urd labeled only 
DNA-Cyt. 
The labeling of DNA-Thy and DNA-Cyt was 
further characterized by determining rates of 
precursor incorporation with [3H]dThd or 
[3H]dUrd and [3H]dCyd or [3H]Urd, respectively, 
as shown in fig.2. All four precursors were incor- 
porated linearly through 12 h and demonstrated 
essentially identical rates though different extents 
of labeling, i.e., [3H]dThd and [3H]dCyd, 
200-360 dpm/nmol pyrimidine; [3H]dUrd and 
[3H]Urd, 22-44 dpm/nmol pyrimidine. Thus, 
while the fate of a specific [3H]nucleoside as a 
DNA-Thy or DNA-Cyt was restricted, the cor- 
responding overall measures of DNA synthesis 
were the same for the nucleosides. 
3.2. Nucleoside incorporation during pyrazofurin- 
blockade of the de novo pathway 
Pyrazofurin is an effective inhibitor of Con A- 
stimulated lymphocyte proliferation via blockage 
of DNA synthesis [16]. It acts through inhibition 
of orotidylate decarboxylase and the subsequent 
supply of de novo pathway pyrimidine nucleotides 
for DNA synthesis [17,18]. We used pyrazofurin to 
determine (i) the relative contribution of 
pyrimidine deoxynucleoside triphosphate from the 
de novo versus salvage pathways for use in lym- 
phocyte proliferation, and (ii) to determine if in- 
hibition of the de novo pathway could alter the 
DNA-labeling distribution of the [3H]nucleosides. 
Pyrazofurin (10/~M) was added at time zero along 
with Con A and was present throughout the 
culture period. The results in fig.3a show that 
while 10/~M pyrazofurin reduced the de novo 
precursor [14C]orotic acid incorporation by 
>90%, its inhibition of the salvage pathway 
[3H]nucleosides was generally only 40-50%. This 
paralleled a 50% inhibition of cell proliferation 
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Fig.2. Rates of DNA synthesis by DNA-Thy and DNA-Cyt specific precursors. 3H-labeled nucleosides were 
incorporated over a 12-h period and DNAs were isolated and analyzed for the radioactivity content of their HPLC Thy 
or Cyt peaks as described in section 2. Individual points represent the mean of 3 experiments and the slope values are 
the mean + SE of the slopes from 3 experiments. (a) DNA-Thy precursors; (b) DNA-Cyt precursors. 
(f ig.3b). When the labeled DNAs from 
pyrazofur in- inhib i ted cultures were hydrolyzed 
and analyzed by HPLC for changes in the distr ibu- 
t ion of  label among DNA-Thy  and DNA-Cyt ,  the 
patterns were identical to those in f ig. l ,  i.e., no 
new patterns of  distr ibut ion appeared.  
The reversal of  pyrazofur in inhibited DNA syn- 
thesis and cell prol i ferat ion by exogenously sup- 
plied Urd has previously been reported for 
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Con A-st imulated rat lymphocytes [16]. A similar 
reversal of  10/tM pyrazofur in- inhib i ted incorpora-  
t ion of  [3H]dThd into DNA and lymphocyte cell 
prol i ferat ion was observed when 75/~M Urd was 
added simultaneously with pyrazofur in  to the 
cultures (fig.3b). None of  the other nucleosides 
studied, i.e. dThd,  dCyd,  dUrd or Cyd, were able 
to reverse pyrazofur in inhibit ion. 
Fig.3. Pyrazofurin inhibition of DNA synthesis and cell 
proliferation. (a) Various radiolabeled DNA precursors 
were incorporated into Con A-stimulated lymphocytes 
in the absence or presence of 10/~M pyrazofurin and the 
level of labeling in isolated DNA determined as 
described in section 2. 0a) Reversal of pyrazofurin- 
inhibited DNA synthesis ([3H]dThd incorporation) and 
cell proliferation (cell no.) by the presence of 75/~M Urd 
during culture. All data are reported as % untreated 
controls and represent means _+ SE for 3 or more 
determinations, dT, dThd; dC, dCyd; dU, dUrd; rU, 
Urd; rC, Cyd; OA, orotic acid; open bars, 10/~M 
pyrazofurin; solid bars, 10/xM pyrazofurin and 75/~M 
Urd. 
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4. DISCUSSION 
The data presented in this communication 
establish that [3H]dThd and [3H]dUrd exclusively 
labeled DNA-Thy, while [3H]dCyd, [3H]Urd and 
[3H]Cyd exclusively labeled DNA-Cyt during DNA 
synthesis in the Con A-stimulated proliferation of 
T-lymphocytes from guinea pig lymph nodes. Fur- 
thermore, the labeling pattern of salvage pathway 
nucleosides is not altered when de novo biosyn- 
thesis of pyrimidines is blocked by pyrazofurin. 
Con A stimulates proliferation primarily among 
T-cell lymphocytes [19]; the accompanying DNA 
synthesis has been characterized as semi- 
conservative DNA replication with no appreciable 
evidence for repair synthesis or selective amplifica- 
tion of certain portions of the genome [20]. As il- 
lustrated in fig.4, entry of [3H]dThd and [3H]dCyd 
into DNA is mediated primarily by phosphoryla- 
tion reactions of the salvage pathway, while entry 
of dUrd, Urd and Cyd also requires the action of 
thymidylate synthetase, CTP synthetase and 
ribonucleoside diphosphate reductase, respective- 
ly. The inability of [3H]Cyd to label DNA-Thy 
confirms a previous report [16] of the absence of 
Cyd deaminase activity in Con A-stimulated T- 
lymphocytes, and also suggests the absence of 
dCMP deaminase activity. An explanation for 
restricted incorporation of [3H]Urd into just DNA- 
Cyt would appear to be more complex. While 
[3H]Urd must utilize ribonucleoside diphosphore- 
ductase as it goes from CDP to dCDP for the 
labeling of DNA-Cyt, it is not reduced by 
ribonucleoside diphosphoreductase in the step 
UDP to dUDP which would allow it to be used as 
a precursor for labeling DNA-Thy. Information 
concerning the differential regulation of the reduc- 
tion of ribonucleotides [21] does not readily ac- 
count for the selective reduction of Urd to dCDP 
but not to dUDP. Furthermore, since [~4C]orotic 
acid labeled both DNA-Thy and DNA-Cyt, it must 
be presumed that either a dCMP deaminase activi- 
ty (dCMP to dUMP to dTMP to dTTP) or UDP 
reductase activity (UDP to dUDP to dUMP to 
dTMP to dTTP) exist intracellularly in order for 
orotic acid to label DNA-Thy. A model of com- 
partmentalization f dNTP pools through precur- 
sor channeling can account for the above 
incorporation patterns. This model would require 
separate de novo and salvage pathway UMP corn- 
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Fig.4. Summary of pyrimidine pathways in eukaryotic 
cells. Solid line arrows indicate routes utilized by Con A- 
stimulated guinea pig lymphocytes to incorporate 
various exogenous nucleosides into DNA. 
partments, one of which would be channeled by a 
de novo multi-enzyme complex with tight coupling 
between UMP synthetase and enzymes needed to 
synthesize both dTTP and dCTP, including 
ribonucleotide reductase, cytidine triphosphate 
synthetase and thymidylate synthetase. A second, 
salvage pathway complex not tightly coupled to 
UMP synthetase and able to channel Urd only to 
dCTP would be required to contain ribonucleotide 
reductase and cytidine triphosphate synthetase ac- 
tivities but not thymidylate synthetase activity. 
Evidence for the existence of a 'replitase' complex 
comprised of ribonucleoside reductase, thymidy- 
late synthetase, topoisomerase, and DNA poly- 
merase cv in HeLa cells has been reported [9]. The 
existence of a similar multi-enzyme complex con- 
taining CTP synthetase and ribonucleoside r duc- 
tase have not been reported, but would be 
predicted to exist in Con A-stimulated guinea pig 
lymphocytes. A similar analysis of the ability of 
various DNA precursors to selectively label DNA- 
Thy and DNA-Cyt of other proliferating cells may 
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prove helpful in establishing an understanding of
nucleoside metabolism as it relates to subcellular 
compartmentalization a d precursor channeling 
by multi-enzyme complexes. 
The ability of exogenous Urd to reverse 
pyrazofurin inhibition while only being incor- 
porated in DNA-Cyt does not support as a 
mechanism for its action the salvage pathway re- 
supply of depleted dTTP and dCTP pools for 
DNA synthesis. Instead, it would appear that Urd 
may act at a level which directly interferes with the 
ability of pyrazofurin to exert its inhibitory in- 
fluence on orotidylate decarboxylase. The ability 
of only Urd among the nucleotides tested to 
reverse pyrazofurin inhibition may be related to re- 
cent observations of selective and concentrative 
Urd uptake by murine splenocytes [22]. Selective 
transport of exogenous Urd by Con A-stimulated 
lymphocytes may provide an intracellular concen- 
tration of Urd sufficient o block pyrazofurin in- 
hibition. Additional studies to establish the precise 
mechanisms for Urd reversal of pyrazofurin in- 
hibition are in progress. 
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